RxDoctor Payments Data

Shyler Demill, DO

Foot and Ankle Surgery · Yakima, WANPI 1942499975

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $20,018 of the $25,979 with a category attached, or 77.1%. Paragon 28, Inc. accounts for 96.5% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2023 at $15,553 and has fallen 92.5% since, to $1,171 in 2025. Among foot and ankle surgery clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$25,979in general payments, 2019–2025

Across 55 payments — averaging $472.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paragon 28, Inc.$25K
  • Heron Therapeutics, Inc.$195
  • Smith+Nephew$156
  • Stryker$99
  • Parcus Medical, LLC$96
  • Johnson & Johnson$94
  • plus $259 from 7 others

What the payments were for

  • Consulting fees$20,01877%
  • Travel & lodging$4,27216%
  • Food & beverage$1,6907%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,979 in reported general payments places this provider in the 90th percentile of 203 foot and ankle surgery providers in Washington.

See all foot and ankle surgery providers in Washington

Medicare billing

Part B allowed, 2024
$132,852
Medicare patients
259
Services billed
1,437

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib78$487
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen61$352
Meloxicam109$234
Tramadol Hcl87$225
Gabapentin74$210
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen35$209
Cephalexin12$143

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Yakima

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →